Inhibition of Streptococcus suis adhesion by dendritic galabiose compounds at low nanomolar concentration

Journal of Medicinal Chemistry

Volumn 47, Issue 26, 2004, Pages 6499-6508

  Joosten, John A F ^a   Loimaranta, Vuokko ^b   Appeldoorn, Chantal C M ^a   Haataja, Sauli ^b   El Maate, Fatna Ait ^a   Liskamp, Rob M J ^a   Finne, Jukka ^b   Pieters, Roland J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 BIS(2 AMINOETHOXYL)BENZOIC ACID; AMIDE; BENZOIC ACID DERIVATIVE; CARBOHYDRATE DERIVATIVE; GALABIOSE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ADHERENCE; DENDRITIC CELL; DRUG CONCENTRATION; DRUG INHIBITION; HEMAGGLUTINATION; MINIMUM INHIBITORY CONCENTRATION; STREPTOCOCCUS SUIS; SURFACE PLASMON RESONANCE; SYNTHESIS;

BACTERIAL ADHESION; DISACCHARIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HEMAGGLUTINATION TESTS; HUMANS; MICROBIAL SENSITIVITY TESTS; OVOMUCIN; STREPTOCOCCUS SUIS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE;

EID: 10644275161     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049476+     Document Type: Article

References (53)

1. Levy, S. B. The challenge of antibiotic resistance. Sci. Am. 1998, 278 (March), 46-53.
2. Johnson, K. F. Synthesis of oligosaccharides by bacterial enzymes. Glycoconjugate J. 1999, 16, 141-146.
3. Ofek, I.; Hasty, D. L.; Sharon, N. Anti-adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunol. Med. Microbiol. 2003, 38, 181-191.
4. Zopf, D.; Roth, S. Oligosaccharide anti-infective agents. Lancet 1996, 347, 1017-1021.
5. Mammen, M.; Choi, S.-K.; Whitesides, G. M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem., Int. Ed. 1998, 37, 2754-2794.
6. (a) Kitov, P. I.; Sadowska, J. M.; Mulvey, G.; Arnstrong, G. D.; Ling, H.; Pannu, N. S.; Read, R. J.; Bundle, D. R. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 2000, 403, 669-672.
7. (b) Kitov, P. I.; Shimizu, H.; Homans, S. W.; Bundle, D. R. Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a Shiga-like toxin. J. Am. Chem. Soc. 2003, 125, 3284-3294.
8. (c) Fan, E.; Zhang, Z.; Minke, W. E.; Hou, Z.; Verlinde, C. L. M. J.; Hol, W. G. J. High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design. J. Am. Chem. Soc. 2000, 122, 2663-2664.
9. (d) Zhang, Z.; Merritt, E. A.; Ahn, M.; Roach, C.; Hou, Z.; Verlinde, C. L. M. J.; Hol, W. G. J.; Fan, E. Solution and cristallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. J. Am. Chem. Soc. 2002, 124, 12991-12998.
10. (e) Arosio, D.; Vrasidas, I.; Valentini, P.; Liskamp, R. M. J.; Pieters, R. J.; Bernardi, A. Synthesis and cholera toxin binding properties of multivalent GM1 mimics. Org. Biomol. Chem. 2004, 2, 2113-2124.
11. (a) Lindhorst, T. K.; Kieburg, C.; Krallmann-Wenzel, U. Inhibition of the type 1 fimbriae-mediated adhesion of Escherichia coli to erythrocytes by multiantennary alpha-mannosyl clusters: The effect of multivalency. Glycoconjugate J. 1998, 15, 605-613.
12. (b) Lindhorst, T. K.; Dubber, M.; Krallmann-Wenzel, U.; Ehlers, S. Cluster mannosides as inhibitors of type 1 fimbriae-mediated adhesion of Escherichia coli: Pentaerythritol derivatives as scaffolds. Eur. J. Org. Chem. 2000, 2027-2035.
13. (c) Lindhorst, T. K.; Kötter, S.; Krallmann-Wenzel, U.; Ehlers, S. Trivalent alpha-D-mannoside clusters as inhibitors of type-1 fimbriae-mediated adhesion of Escherichia coli: structural variation and biotinylation. J. Chem. Soc., Perkin Trans 1 2001, 823-831.
14. Nagahori, N.; Lee, R. T.; Nishimura, SA.; Pagé, D.; Roy, R.; Lee, Y. C. Inhibition of adhesion of type 1 fimbriated Escherichia coli to highly mannosylated ligands. ChemBioChem 2002, 3, 836-844.
15. Autar, R.; Khan, A. S.; Schad, M.; Hacker, J.; Liskamp, R. M. J.; Pieters, R. J. Adhesion inhibition of F1C-fimbriated Escherichia coli and Pseudomonas aeruginosa PAK and PAO by multivalent carbohydrate ligands. ChemBioChem 2003, 4, 1317-1325.
16. Hansen, H. C.; Haataja, S.; Finne, J.; Magnusson, G. Di-, tri-, and tetravalent dendritic galabiosides that inhibit hemagglutination by Streptococcus suis at nanomolar concentration. J. Am. Chem. Soc. 1997, 119, 6974-6979.
17. Arends, J. P.; Zanen, H. C. Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 1988, 10, 131-137.
18. Staats, J. J.; Feder, I.; Okwumabua, O.; Chengappa, M. M. Streptococcus suis: Past and present. Vet. Res. Commun. 1997, 21, 381-407.
19. (a) Bock, K.; Breimer, M. E.; Brignoleg, A.; Hansson, G. C.; Karlssong, K.-A.; Larson, G.; Leffler, H.; Samuelsson, B. E.; Stromberg, N.; Eden, C. S.; Thurin, J. Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1-4Gal-containing glycosphingolipids. J. Biol. Chem. 1985, 260, 8545-8551.
20. (b) Roberts, J. A.; Marklund, B. I.; Ilver, D.; Haslam, D.; Kaack, M. B.; Baskin, G.; Louis, M.; Mollby, R.; Winberg, J.; Normark, S. The Gal(alpha-1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11889-11893.
21. (c) Stapleton, A. E.; Stroud, M. R.; Hakomori, S. I.; Stamm, W. E. The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred binding receptor in vitro for uropathogenic Escherichia coli expressing pap-encoded adhesins. Infect. Immun. 1998, 66, 3856-3861.
22. (a) Gilboa-Garber, N.; Sudakevitz, D.; Sheffi, M.; Sela, R.; Levene, C. Paid interactions with the APO(H)-blood and P-blood group glycosphingolipid antigens may contribute to the broadspectrum adherance of Pseudomonas aeruginosa to human tissues in secondary infections. Glycoconjugate J. 1994, 11, 414-417.
23. (b) Chen, C.-P.; Song, S.-C.; Gilboa-Garber, N.; Chang, K. S. S.; Wu, A. M. Studies on the binding site of the galactose-specific agglutinin PA-IL from Pseudomonas aeruginosa. Glycobiology 1998, 5, 7-16.
24. Lindberg, A. A.; Brown, J. E.; Stromberg, N.; Westerling-Ryd, M.; Schultz, J. E.; Karlsson, K.-A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 1987, 262, 1779-1785.
25. Lingwood, C. A.; Law, H.; Richardson, S.; Petric, M.; DeGrandis, S.; Brunton, J. L.; Karmali, M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 1987, 262, 8834-8839.
26. Haataja, S.; Tikkanen, K.; Liukkonen, J.; François-Gerard, C.; Finne, J. Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides. J. Biol. Chem. 1993, 268, 4311-4317.
27. Haataja, S.; Tikkanen, K.; Nilsson, U.; Magnusson, G.; Karlsson, K.-A.; Finne, J. Oligosaccharide-receptor interaction of the Ga1αl-4Gal binding adhesin of Streptococcus suis combining site architecture and characterization of 2 variant adhesin specificities. J. Biol. Chem. 1994, 269, 27466-27472.
28. Haataja, S.; Zhang, Z.; Tikkanen, K.; Magnusson, G.; Finne, J. Determination of the cell adhesion specificity of Streptococcus suis with the complete set of monodeoxy analogues of globotriose. Glycoconjugate J. 1999, 16, 67-71.
29. 5 toxins: structures and inhibitor design. Curr. Opin. Struct. Biol. 2000, 10, 680-686.
30. Motawia, M. S.; Olsen, C. E.; Denyer, K.; Smith, A. M.; Moller, B. L. Synthesis of 4′-O-acetyl-maltose and α-D-galactopyranosyl-(1-4)-D- glucopyranose for biochemical studies of amylose biosynthesis. Carbohydr. Res. 2001, 330, 309-318.
31. Gandolfi-Donadio, L.; Gallo-Rodriguez, C.; de Lederkremer, R. M. Synthesis of α-D-Ga1p-(1-3)-β-D-Ga1f-(1-3)-D-Man, a terminal trisaccharide of Leishmania type-2 glycoinositolphospholipids. J. Org. Chem. 2002, 67, 4430-4435.
32. De Ninno, M. P.; Etienne, J. B.; Duplantier, K. C. A method for the selective reduction of carbohydrate 4,6-O-benzylidene acetals. Tetrahedron Lett. 1995, 36, 669-672.
33. Wulff, G.; Röhle, G. Results and problems of O-glycoside synthesis. Angew. Chem., Int. Ed. Engl. 1974, 13, 157-170.
34. Reddy, P. G.; Pratap, T. V.; Kumar, G. D. K.; Mohanty, S. K.; Baskaran, S. The Lindlar catalyst revitalized: A highly chemoselective method for the direct conversion of azides to N-(tert-butoxycarbonyl)amines. Eur. J. Org. Chem. 2002, 3740-3743.
35. Mulders, S. J. E.; Brouwer, A. J.; Liskamp, R. M. J. Molecular diversity of novel amino acid based dendrimers. Tetrahedron Lett. 1997, 38, 3085-3088.
36. Brouwer, A. J.; Mulders, S. J. E.; Liskamp, R. M. J. Convergent synthesis and diversity of amino acid based dendrimers. Eur. J. Org. Chem. 2001, 1903-1915.
37. (a) Vrasidas, I.; de Mol, N. J.; Liskamp, R. M. J.; Pieters, R. J. Synthesis of lactose dendrimers and multivalency effects in binding to the cholera toxin B subunit. Eur. J. Org. Chem. 2001, 4685-4692.
38. (b) André, S.; Pieters, R. J.; Vrasidas, I.; Kaltner, H.; Kuwabara, I.; Liu, F.-T.; Liskamp, R. M. J.; Gabius, H.-J. Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates. ChemBioChem 2001, 2, 822-830.
39. (c) Pieters, R. J. Interference with Lectin Binding and Bacterial Adhesion by Multivalent Carbohydrates and Peptidic Carbohydrate Mimics. Trends Glycosci. Glycotechnol. 2004, 16, 243-254.
40. Marshall, J. A.; Zou, D. A new synthesis of 3-carboxy-2,5-disubstituted furans and their conversion to 5-vinyl derivatives. Tetrahedron Lett. 2002, 41, 1347-1350.
41. Vrasidas, I.; Kemmink, J.; Liskamp, R. M. J.; Pieters, R. J. Synthesis and cholera toxin binding properties of a lactose-2-aminothiazoline conjugate. Org. Lett. 2002, 4, 1807-1808.
42. Tomalia, D. A.; Naylor, A. M.; Goddard, W. A., III Starburst dendrimers - Molecular level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem., Int. Ed. Engl. 1990, 29, 138-175.
43. (a) Aoi, K.; Tsutsumiuchi, K.; Yamamoto, A.; Okada, M. Globular carbohydrate macromolecule "sugar balls" 3. "Radial-growth polymerization" of sugar-substituted α-amino acid N-carboxyanhydrides (GlycoNCAs) with a dendritic initiator. Tetrahedron 1997, 53, 15415-15427.
44. (b) Page, D.; Roy, R. Synthesis and biological properties of mannosylated starburst poly(amidoamine) dendrimers. Bioconjugate Chem. 1997, 8, 714-723.
45. (c) Zanini, D.; Roy, R. Practical synthesis of starburst PAMAM α-thiosialodendrimers for probing multivalent carbohydrate-lectin binding properties. J. Org. Chem. 1998, 63, 3486-3491.
46. (e) Choudhury, A. K.; Kitaoka, M.; Hayashi, K. Synthesis of a cellobiosylated dimer and trimer and of cellobiose-coated polyamidoamine (PAMAM) dendrimers to study accessibility of an enzyme, cellodextrin phosphorylase. Eur. J. Org. Chem. 2003, 2462-2470.
47. (f) Woller, E. K.; Walter, E. D.; Morgan, J. R.; Singel, D. J.; Cloninger, M. J. Altering the strength of lectin binding interactions and controlling the amount of lectin clustering using mannose/hydroxyl- functionalized dendrimers. J. Am. Chem. Soc. 2003, 125, 8820-8826.
48. Baek, M.-G.; Roy, R. Synthesis and protein binding properties of T-antigen containing GlycoPAMAM dendrimers. Bioorg. Med. Chem. 2002, 10, 11-17.
49. Lundquist, J. J.; Toone, E. J. The cluster glycoside effect. Chem. Rev. 2002, 102, 555-578.
50. (a) Mulvey, G. L.; Marcato, P.; Kitov, P. I.; Sadowska, J.; Bundle, D. R.; Armstrong, G. D. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J. Infect. Dis. 2003, 187, 640-649.
51. (b) Nishikawa, K.; Matsuoka, K.; Kita, E.; Okabe, N.; Mizuguchi, M.; Hino, K.; Miyazawa, S.; Yamasaki, C.; Aoki, J.; Takashima, S.; Yamakawa, Y.; Nishijima, M.; Terunuma, D.; Kuzuhara, H.; Natori, Y. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157: H7. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 7669-7674.
52. Korhonen, T. K; Finne, J. In Enterobacterial surface antigens: methods for molecular characterization; Korhonen, T. K., Dawes, E. A., Mäkelä, P. H., Eds.; Elsevier Science Publishers: Amsterdam, 1985; pp 301-313.
53. Senpuku, H.; Matin, K.; Abdus, S. M. D.; Kurauchi, I.; Sakurai, S.; Kawashima, M.; Murata, T.; Miyazaki, H.; Hanada, N. Inhibitory effects of MoAbs against a surface protein antigen in real-time adherence in vitro and recolonization in vivo of Streptococcus mutans. Scand. J. Immunol. 2001, 54, 109-116.